Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: Economic evaluation of a randomised controlled trial

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Meeuwsen, Els ^a   Melis, René ^a   Van Der Aa, Geert ^b   Golüke Willemse, Gertie ^c   De Leest, Benoit ^d   Van Raak, Frank ^e   Schölzel Dorenbos, Carla ^f   Verheijen, Desiree ^g   Verhey, Frans ^h   Visser, Marieke ⁱ   Wolfs, Claire ^h   Adang, Eddy ^a   Rikkert, Marcel Olde ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d ELKERLIEK HOSPITAL   (Netherlands)

^e Mental Health Organisation Oost Brabant   (Netherlands)

^f SLINGELAND HOSPITAL   (Netherlands)

^g GELDERSE VALLEI HOSPITAL   (Netherlands)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CAREGIVER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMENTIA; ECONOMICS; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; MALE; MEMORY; OUTPATIENT DEPARTMENT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; CAREGIVERS; COST-BENEFIT ANALYSIS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HUMANS; MALE; MEMORY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84894268408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079797     Document Type: Article

References (34)

1. Jonsson L, Wimo A (2009) The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics., 27, 391-403.
2. Wimo A, Winblad B, Jonsson L (2010) The worldwide societal costs of dementia: Estimates for 2009. Alzheimers. Dement., 6, 98-103.
3. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, et al. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med., 367, 795-804.
4. Alzeimer Europe (2012) Available: http://www.alzheimer-europe.org/Policy- in-Practice2/National-Dementia-Plans.Accessed 2013 Oct 11.
5. Burns A, Robert P (2009) The National Dementia strategy in England. BMJ, 338, b931.
6. Cahill S (2010) Developing a national dementia strategy for Ireland. Int. J. Geriatr. Psychiatry, 25, 912-916.
7. Department of Health (2009) Living well with dementia: a National Dementia Strategy. London: Department of Health website. Available: https://www.gov.uk/government/publications/living-well-with-dementia-a-national- dementiastrategy. Accessed 2013 Oct 11.
8. Eriksson S (2010) Developments in dementia strategy. Int. J. Geriatr. Psychiatry, 25, 885-886.
9. Jolley D, Benbow SM, Grizzell M (2006) Memory clinics. Postgrad. Med. J., 82, 199-206.
10. Passmore AP, Craig DA (2004) The future of memory clinics. Psychiatric Bulletin, 28, 375-377. (Pubitemid 39359700)
11. Ramakers IH, Verhey FR (2011) Development of memory clinics in the Netherlands: 1998 to 2009. Aging Ment. Health, 15, 34-39.
12. Wolfs CA, Dirksen CD, Kessels A, Severens JL, Verhey FR (2009) Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch. Gen. Psychiatry, 66, 313-323.
13. Melis RJ, Meeuwsen EJ, Parker SG, Olde Rikkert MGM (2009) Are memory clinics effective? The odds are in favour of their benefit, but conclusive evidence is not yet available. J. R. Soc. Med., 102, 456-457.
14. Knapp M, Iemmi V, Romeo R (2012) Dementia care costs and outcomes: a systematic review. Int. J. Geriatr. Psychiatry, DOI: 10.1002/gps.3864.
15. Meeuwsen EJ, Melis RJ, Van Der Aa GCHM, Goluke-Willemse GAM, De Leest BJM, et al. (2012) Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ, 344, e3086.
16. Meeuwsen EJ, Melis RJ, Adang EM, Goluke-Willemse GA, Krabbe PF, et al. (2009) Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J. Nutr. Health Aging, 13, 242-248.
17. Richtlijn CBO (2005) Diagnostiek en medicamenteuze behandeling van dementie Alphen aan den Rijn, (in Dutch).
18. Boomsma LJ, De Bont M, Engelsman C, Gussekloo J, Hartman C, et al. (2005) Landelijke Eerstelijns Samenwerkings Afspraak Dementie. Huisarts Wet, 48, 124-126 (in Dutch). (Pubitemid 40362662)
19. Nederlands Huisartsen Genootschap (2003) NHG-Standaard Dementie M21 (in Dutch).
20. Jonsson L, Andreasen N, Kilander L, Soininen H, Waldemar G, et al. (2006) Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. Alzheimer Dis. Assoc. Disord., 20, 49-55. (Pubitemid 44356894)
21. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ (2005) [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned. Tijdschr. Geneeskd., 149, 1574-1578.
22. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ (2006) The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ., 15, 1121-1132. (Pubitemid 44596379)
23. Dolan P (1997) Modeling valuations for EuroQol health states. Med. Care, 35, 1095-1108.
24. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the economic evaluation of health care programmes. (Third ed.) Oxford University Press.
25. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH (2004) Handleiding voor kostenonderzoek; Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie 2004 College voor zorgverzekeringen (CVZ) (in Dutch).
26. CBS (2009) Statistics Netherlands website. Available: http://statline.cbs.nl/statweb/. Accessed 2013 Oct 11.
27. Wimo A, Nordberg G (2007) Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument. Arch. Gerontol. Geriatr., 44, 71-81. (Pubitemid 44781118)
28. van Hout BA, Al MJ, Gordon GS, Rutten FF (1994) Costs, effects and C/Eratios alongside a clinical trial. Health Econ., 3, 309-319.
29. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State - Practical Method for Grading Cognitive State of Patients for Clinician. Journal of psychiatric research, 12, 189-198.
30. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, et al. (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res., 41, 237-248.
31. Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jonsson L, et al. (2008) Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ, 336, 134-138. (Pubitemid 351216996)
32. Krol M, Brouwer W, Sendi P (2006) Productivity costs in health-state valuations : does explicit instruction matter? Pharmacoeconomics 24, 401-414.
33. U.S.Department of Health and Human Services (2012) National Plan to address Alzheimer's disease - National Alzheimer's Project Act (NAPA). Alzheimers. Dement., 8, 234-236.
34. World Health Organization, Alzheimer's Disease International (2012) Dementia: a public health priority WHO press.